Coverage of atypical antipsychotics among medicare drug plans in the state of Washington: Changes between 2007 and 2008

Meng Yun Wu, Jae Kennedy, Lawrence J. Cohen, Chi Chuan Wang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To examine changes in the cost and coverage of atypical antipsychotics among Medicare prescription drug plans and Medicare advantage plans in the state of Washington. Method: Coverage and cost data were obtained in February 2007 and 2008 from the Medicare Prescription Drug Plan Finder, an online database administered by the Centers for Medicare and Medicaid Services. Premiums, deductibles, out-of-pocket costs, and coverage limits were compared for prescription drug plans (PDPs) and for Medicare advantage plans (MAPs). Results: The number of PDPs in the state of Washington fell slightly from 57 in 2007 to 53 in 2008, while the number of MAPs rose from 43 in 2007 to 52 in 2008. In 2008, the mean monthly drug premium increased by 15% among PDPs and by 20% among MAPs. Mean copayments for the majority of atypical antipsychotics increased from 2007 to 2008. More plans added quantity limits for atypical antipsychotics, but use of other pharmacy management tools varied by type of plan and antipsychotic. Conclusions: PDP and MAP participants in the state of Washington paid more for atypical antipsychotics in 2008 than they did in 2007. Affordability of atypical antipsychotics continues to be a concern, particularly for beneficiaries who are not eligible for Medicaid or the low-income subsidy.

Original languageEnglish
Pages (from-to)316-321
Number of pages6
JournalPrimary Care Companion to the Journal of Clinical Psychiatry
Volume11
Issue number6
DOIs
StatePublished - 1 Dec 2009

Fingerprint

Medicare Part C
Prescription Drugs
Medicare
Antipsychotic Agents
Pharmaceutical Preparations
Deductibles and Coinsurance
Costs and Cost Analysis
Centers for Medicare and Medicaid Services (U.S.)
Medicaid
Health Expenditures
Databases

Cite this

@article{10771d72b2174100ac4bcf258eabef74,
title = "Coverage of atypical antipsychotics among medicare drug plans in the state of Washington: Changes between 2007 and 2008",
abstract = "Objective: To examine changes in the cost and coverage of atypical antipsychotics among Medicare prescription drug plans and Medicare advantage plans in the state of Washington. Method: Coverage and cost data were obtained in February 2007 and 2008 from the Medicare Prescription Drug Plan Finder, an online database administered by the Centers for Medicare and Medicaid Services. Premiums, deductibles, out-of-pocket costs, and coverage limits were compared for prescription drug plans (PDPs) and for Medicare advantage plans (MAPs). Results: The number of PDPs in the state of Washington fell slightly from 57 in 2007 to 53 in 2008, while the number of MAPs rose from 43 in 2007 to 52 in 2008. In 2008, the mean monthly drug premium increased by 15{\%} among PDPs and by 20{\%} among MAPs. Mean copayments for the majority of atypical antipsychotics increased from 2007 to 2008. More plans added quantity limits for atypical antipsychotics, but use of other pharmacy management tools varied by type of plan and antipsychotic. Conclusions: PDP and MAP participants in the state of Washington paid more for atypical antipsychotics in 2008 than they did in 2007. Affordability of atypical antipsychotics continues to be a concern, particularly for beneficiaries who are not eligible for Medicaid or the low-income subsidy.",
author = "Wu, {Meng Yun} and Jae Kennedy and Cohen, {Lawrence J.} and Wang, {Chi Chuan}",
year = "2009",
month = "12",
day = "1",
doi = "10.4088/PCC.08m00737",
language = "English",
volume = "11",
pages = "316--321",
journal = "Primary Care Companion to the Journal of Clinical Psychiatry",
issn = "1523-5998",
publisher = "Physicians Postgraduate Press Inc.",
number = "6",

}

Coverage of atypical antipsychotics among medicare drug plans in the state of Washington : Changes between 2007 and 2008. / Wu, Meng Yun; Kennedy, Jae; Cohen, Lawrence J.; Wang, Chi Chuan.

In: Primary Care Companion to the Journal of Clinical Psychiatry, Vol. 11, No. 6, 01.12.2009, p. 316-321.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Coverage of atypical antipsychotics among medicare drug plans in the state of Washington

T2 - Changes between 2007 and 2008

AU - Wu, Meng Yun

AU - Kennedy, Jae

AU - Cohen, Lawrence J.

AU - Wang, Chi Chuan

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Objective: To examine changes in the cost and coverage of atypical antipsychotics among Medicare prescription drug plans and Medicare advantage plans in the state of Washington. Method: Coverage and cost data were obtained in February 2007 and 2008 from the Medicare Prescription Drug Plan Finder, an online database administered by the Centers for Medicare and Medicaid Services. Premiums, deductibles, out-of-pocket costs, and coverage limits were compared for prescription drug plans (PDPs) and for Medicare advantage plans (MAPs). Results: The number of PDPs in the state of Washington fell slightly from 57 in 2007 to 53 in 2008, while the number of MAPs rose from 43 in 2007 to 52 in 2008. In 2008, the mean monthly drug premium increased by 15% among PDPs and by 20% among MAPs. Mean copayments for the majority of atypical antipsychotics increased from 2007 to 2008. More plans added quantity limits for atypical antipsychotics, but use of other pharmacy management tools varied by type of plan and antipsychotic. Conclusions: PDP and MAP participants in the state of Washington paid more for atypical antipsychotics in 2008 than they did in 2007. Affordability of atypical antipsychotics continues to be a concern, particularly for beneficiaries who are not eligible for Medicaid or the low-income subsidy.

AB - Objective: To examine changes in the cost and coverage of atypical antipsychotics among Medicare prescription drug plans and Medicare advantage plans in the state of Washington. Method: Coverage and cost data were obtained in February 2007 and 2008 from the Medicare Prescription Drug Plan Finder, an online database administered by the Centers for Medicare and Medicaid Services. Premiums, deductibles, out-of-pocket costs, and coverage limits were compared for prescription drug plans (PDPs) and for Medicare advantage plans (MAPs). Results: The number of PDPs in the state of Washington fell slightly from 57 in 2007 to 53 in 2008, while the number of MAPs rose from 43 in 2007 to 52 in 2008. In 2008, the mean monthly drug premium increased by 15% among PDPs and by 20% among MAPs. Mean copayments for the majority of atypical antipsychotics increased from 2007 to 2008. More plans added quantity limits for atypical antipsychotics, but use of other pharmacy management tools varied by type of plan and antipsychotic. Conclusions: PDP and MAP participants in the state of Washington paid more for atypical antipsychotics in 2008 than they did in 2007. Affordability of atypical antipsychotics continues to be a concern, particularly for beneficiaries who are not eligible for Medicaid or the low-income subsidy.

UR - http://www.scopus.com/inward/record.url?scp=77957668184&partnerID=8YFLogxK

U2 - 10.4088/PCC.08m00737

DO - 10.4088/PCC.08m00737

M3 - Article

C2 - 20098523

AN - SCOPUS:77957668184

VL - 11

SP - 316

EP - 321

JO - Primary Care Companion to the Journal of Clinical Psychiatry

JF - Primary Care Companion to the Journal of Clinical Psychiatry

SN - 1523-5998

IS - 6

ER -